Compare OESX & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OESX | CPIX |
|---|---|---|
| Founded | 1996 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 108.4M | 98.3M |
| IPO Year | 2007 | 2007 |
| Metric | OESX | CPIX |
|---|---|---|
| Price | $27.25 | $6.39 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $17.50 | N/A |
| AVG Volume (30 Days) | ★ 86.9K | 66.6K |
| Earning Date | 02-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 58.70 |
| EPS | ★ 0.47 | N/A |
| Revenue | ★ $86,306,000.00 | $42,010,949.00 |
| Revenue This Year | $7.94 | N/A |
| Revenue Next Year | $13.89 | N/A |
| P/E Ratio | $58.72 | ★ N/A |
| Revenue Growth | 8.26 | ★ 16.75 |
| 52 Week Low | $7.85 | $1.85 |
| 52 Week High | $31.00 | $9.28 |
| Indicator | OESX | CPIX |
|---|---|---|
| Relative Strength Index (RSI) | 67.61 | 39.53 |
| Support Level | $8.98 | $5.55 |
| Resistance Level | N/A | $8.27 |
| Average True Range (ATR) | 2.50 | 0.62 |
| MACD | 0.25 | -0.20 |
| Stochastic Oscillator | 78.15 | 6.25 |
Orion Energy Systems Inc provide light emitting diode (LED) lighting systems, wireless Internet of Things (IoT) enabled control solutions, commercial and industrial electric vehicle charging infrastructure solutions and lighting and electrical maintenance services. It help its customers achieve their sustainability, energy savings and carbon footprint reduction goals through technology and exceptional service. It sell its products and services into many vertical markets within the broader commercial and industrial market segment. Primary verticals include box retail, manufacturing, warehousing/logistics, federal and municipal government, healthcare and schools. It has three segments Lighting, Maintenance, and EV segment. It generates majority of revenue from Lighting segment.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.